Skip to main content
Neurology logoLink to Neurology
. 2023 Mar 14;100(11):545. doi: 10.1212/WNL.0000000000206876

Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages

Implications for Clinical Alzheimer Trials

PMCID: PMC10499411  PMID: 36690458

In the Research Article entitled “Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials” by Borland et al.,1 under the Cognitive Tests section, the sentence “Further explanation of tests, what they assess, and how points are counted are described in eMethods.” should include the following link to the eMethods: links.lww.com/WNL/C167. The publisher regrets the omission.

Reference

  • 1.Borland E, Edgar C, Stomrud E, Cullen N, Hansson O, Palmqvist S. Clinically relevant changes for cognitive outcomes in preclinical and prodromal cognitive stages: implications for clinical Alzheimer trials. Neurology. 2022;99(11):e1142-e1153. doi: 10.1212/wnl.0000000000200817. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES